VBI Vaccines (VBIV) Reports New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Presentation title: "Long-Term Persistence of Anti-HBs Antibodies after Vaccination with a 3-Antigen HBV Vaccine Compared with a Single-Antigen HBV Vaccine" VBI Vaccines Inc. (Nasdaq: VBIV) (VBI)